Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats (V体育平台登录)
- PMID: 19551842
- PMCID: PMC2829382
- DOI: 10.1002/ijc.24689
"V体育官网入口" Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats
Abstract
Epidemiological and experimental studies provide supportive evidence that lycopene (LY), a major carotenoid from tomatoes and tomato products, may act as a chemopreventive agent against certain types of cancers VSports手机版. We recently showed that high-fat diet (HFD)-induced nonalcoholic steatohepatitis (NASH) promoted diethylnitrosamine (DEN)-initiated hepatocarcinogenesis in a rat model. Using this model, we investigated the efficacy of an equivalent dosage of dietary LY from either a pure compound or a tomato extract (TE) against NASH-promoted hepatocarcinogenesis. Six groups of rats were injected with DEN and then fed either Lieber-DeCarli control diet or HFD with or without LY or TE for 6 weeks. Results showed that both LY and TE supplementations significantly decreased the number of altered hepatic foci expressing the placental form of glutathione S-transferase in the livers of HFD-fed rats. This was associated with significantly lower proliferating cell nuclear antigen positive hepatocytes and cyclinD1 protein, as well as decreased activation of extracellular signal-regulated kinase and nuclear NF-kappaB. Although both LY and TE supplementations reduced HFD-induced lipid peroxidation in the livers, we observed significantly decreased cytochrome P450 2E1, inflammatory foci and mRNA expression of proinflammatory cytokines (TNF-alpha, IL-1beta and IL-12) in the HFD+TE fed group but increased nuclear NF-E2-related factor-2 and heme oxygenase-1 proteins in the HFD+LY fed group, relative to HFD feeding alone. These data indicate that LY and TE can inhibit NASH-promoted hepatocarcinogenesis mainly as a result of reduced oxidative stress, which could be fulfilled through different mechanisms. .
Conflict of interest statement
Author Disclosures: Yan Wang, Lynne M. Ausman, Andrew S V体育安卓版. Greenberg, Robert M. Russell and Xiang-Dong Wang have no conflicts of interest.
"V体育官网" Figures




V体育安卓版 - References
-
- Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis. 2007;11:191–207. - PubMed
-
- Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, Kurokawa F, Maeyama S, Okita K. Hepatocellular carcinoma with nonalcoholic steatohepatitis. J Gastroenterol. 2004;39:391–6. - PubMed
-
- Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, Takasaki K, Ludwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002;37:154–60. - PubMed
-
- Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int. 2001;51:127–31. - PubMed (VSports最新版本)
-
- Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74–80. - PubMed
Publication types (VSports手机版)
- Actions (V体育2025版)
MeSH terms
- VSports最新版本 - Actions
- Actions (V体育ios版)
- Actions (V体育安卓版)
- V体育ios版 - Actions
- V体育平台登录 - Actions
- V体育ios版 - Actions
- "V体育官网" Actions
- "VSports手机版" Actions
- V体育官网 - Actions
- V体育官网 - Actions
- Actions (V体育ios版)
- Actions (VSports在线直播)
- "VSports app下载" Actions
- V体育ios版 - Actions
- "VSports app下载" Actions
- Actions (V体育ios版)
Substances
- Actions (VSports注册入口)
- VSports在线直播 - Actions
- "VSports在线直播" Actions
V体育官网 - Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical (VSports注册入口)